CK Regeon Selected for Korea’s Deep-Tech TIPS Program to Advance Hair Loss Candidate CKR-051 Toward Phase 2
CK Regeon (CEO Kang-Yeol Choi), a tissue regeneration drug developer, has been selected for the Ministry of SMEs and Startups’ Deep-Tech TIPS program to move its hair loss treatment candidate, CKR-051, into Phase 2 clinical development.
November 4, 2026






.png)
















